Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Top Paid Women in Biopharma
GEN recently published a list of the 20 top paid women executives in biopharma. While we were working on that list, we couldn’t help but notice that the women who made the list still had much lower salaries than the men who made our list of what the top 15 biopharma CEOs are making. Do you think those female execs aren’t being paid enough?